Literature DB >> 3265330

Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.

F Stirpe1, E J Wawrzynczak, A N Brown, R E Knyba, G J Watson, L Barbieri, P E Thorpe.   

Abstract

The ribosome-inactivating proteins, bryodin, from Bryonia dioica, and momordin, from Momordica charantia, were coupled by a disulphide bond to a monoclonal anti-Thy 1.1 antibody (OX7). Both immunotoxins were specifically cytotoxic to the Thy 1.1-expressing mouse lymphoma cell line AKR-A in vitro. The OX7-bryodin immunotoxins were the more powerfully toxic and reduced protein synthesis in AKR-A cells by 50% at a concentration of 1-4 x 10(-11) M as compared with 1 x 10(-9) M for the OX7-momordin immunotoxins. Neither of the immunotoxins was toxic to mouse lymphoma EL4 cells, which lack the Thy 1.1 antigen, at concentrations up to 3 x 10(-8) M. Further, bryodin and momordin immunotoxins made from an antibody (R10) of irrelevant specificity were without effect on AKR-A cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265330      PMCID: PMC2246839          DOI: 10.1038/bjc.1988.258

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

Review 1.  Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.

Authors:  E J Wawrzynczak; P E Thorpe
Journal:  Cancer Treat Res       Date:  1988

Review 2.  Prevention of carbohydrate-mediated clearance of ricin-containing immunotoxins by the liver.

Authors:  D C Blakey; P E Thorpe
Journal:  Cancer Treat Res       Date:  1988

3.  The kinetics of antibody binding to membrane antigens in solution and at the cell surface.

Authors:  D W Mason; A F Williams
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

4.  Targeting of the antiviral protein from Phytolacca americana with an antibody.

Authors:  Y Masuho; K Kishida; T Hara
Journal:  Biochem Biophys Res Commun       Date:  1982-03-30       Impact factor: 3.575

5.  Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon).

Authors:  L Barbieri; M Zamboni; E Lorenzoni; L Montanaro; S Sperti; F Stirpe
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

6.  Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.

Authors:  P E Thorpe; A N Brown; W C Ross; A J Cumber; S I Detre; D C Edwards; A J Davies; F Stirpe
Journal:  Eur J Biochem       Date:  1981-06-01

7.  Properties of the ribosome-inactivating proteins gelonin, Momordica charantia inhibitor, and dianthins.

Authors:  A Falasca; A Gasperi-Campani; A Abbondanza; L Barbieri; F Stirpe
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

8.  An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.

Authors:  C F Scott; V S Goldmacher; J M Lambert; J V Jackson; G D McIntyre
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

9.  Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.

Authors:  P E Thorpe; D C Blakey; A N Brown; P P Knowles; R E Knyba; P M Wallace; G J Watson; E J Wawrzynczak
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

10.  Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells.

Authors:  H E Blythman; P Casellas; O Gros; P Gros; F K Jansen; F Paolucci; B Pau; H Vidal
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

View more
  4 in total

1.  An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.

Authors:  A Dinota; L Barbieri; M Gobbi; P L Tazzari; S Rizzi; A Bontadini; A Bolognesi; S Tura; F Stirpe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

Review 2.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.

Authors:  Andrea Bolognesi; Massimo Bortolotti; Maria Giulia Battelli; Letizia Polito
Journal:  Molecules       Date:  2017-01-27       Impact factor: 4.411

4.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.